160 related articles for article (PubMed ID: 31848933)
21. Post authorization safety study comparing quetiapine to risperidone and olanzapine.
Heintjes EM; Overbeek JA; Penning-van Beest FJ; Brobert G; Herings RM
Hum Psychopharmacol; 2016 Jul; 31(4):304-12. PubMed ID: 27297785
[TBL] [Abstract][Full Text] [Related]
22. Diagnoses and prescriptions of antidepressants in suicides: Register findings from the Friuli Venezia Giulia Region, Italy, 2002-2008.
Castelpietra G; Bovenzi M; Clagnan E; Barbone F; Balestrieri M; Isacsson G
Int J Psychiatry Clin Pract; 2016; 20(2):121-4. PubMed ID: 27052194
[TBL] [Abstract][Full Text] [Related]
23. Sick-leave measures, socio-demographic factors and health care as risk indicators for suicidal behavior in patients with depressive disorders--a nationwide prospective cohort study in Sweden.
Wang M; Alexanderson K; Runeson B; Mittendorfer-Rutz E
J Affect Disord; 2015 Mar; 173():201-10. PubMed ID: 25462417
[TBL] [Abstract][Full Text] [Related]
24. Low-dose Quetiapine for Major Depressive Disorder and Sleep Improvement.
Peters EM; Bowen R; Balbuena L
J Clin Psychopharmacol; 2020; 40(5):500-502. PubMed ID: 32796393
[No Abstract] [Full Text] [Related]
25. Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder.
Vieta E; Bauer M; Montgomery S; McIntyre RS; Szamosi J; Earley WR; Eriksson H
J Affect Disord; 2013 Sep; 150(2):639-43. PubMed ID: 23497790
[TBL] [Abstract][Full Text] [Related]
26. Use of antidepressants and risk of repeat self-harm in older adults 75+ with nonfatal self-harm: A 1-year prospective national study.
Hedna K; Montuori C; Forte A; Pompili M; Waern M
Pharmacoepidemiol Drug Saf; 2022 Feb; 31(2):206-213. PubMed ID: 34687250
[TBL] [Abstract][Full Text] [Related]
27. Antidepressants and suicide among young women in Sweden 1999-2013.
Larsson J
Int J Risk Saf Med; 2017; 29(1-2):101-106. PubMed ID: 28885220
[TBL] [Abstract][Full Text] [Related]
28. Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.
Bauer M; Thase ME; Liu S; Earley W; Eriksson H
J Psychopharmacol; 2015 May; 29(5):565-74. PubMed ID: 25257148
[TBL] [Abstract][Full Text] [Related]
29. Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study).
Marwood L; Taylor R; Goldsmith K; Romeo R; Holland R; Pickles A; Hutchinson J; Dietch D; Cipriani A; Nair R; Attenburrow MJ; Young AH; Geddes J; McAllister-Williams RH; Cleare AJ
BMC Psychiatry; 2017 Jun; 17(1):231. PubMed ID: 28651526
[TBL] [Abstract][Full Text] [Related]
30. Sunshine, temperature and suicidal behaviour in patients treated with antidepressants: an explorative nested case-control study.
Makris GD; White RA; Reutfors J; Ekselius L; Andersen M; Papadopoulos FC
Sci Rep; 2021 May; 11(1):10178. PubMed ID: 33986315
[TBL] [Abstract][Full Text] [Related]
31. Antidepressant medication might increase the risk of self-harm injuries: findings in 17 OECD countries.
Högberg GN; Bremberg SG
Eur J Public Health; 2019 Apr; 29(2):365-367. PubMed ID: 30590506
[TBL] [Abstract][Full Text] [Related]
32. Prognoses after self-harm in youth: exploring the gender factor.
Beckman K; Lysell H; Haglund A; Dahlin M
Soc Psychiatry Psychiatr Epidemiol; 2019 Apr; 54(4):437-444. PubMed ID: 30406282
[TBL] [Abstract][Full Text] [Related]
33. Antidepressant medication prevents suicide in depression.
Isacsson G; Reutfors J; Papadopoulos FC; Ösby U; Ahlner J
Acta Psychiatr Scand; 2010 Dec; 122(6):454-60. PubMed ID: 20384599
[TBL] [Abstract][Full Text] [Related]
34. Suicide risk during antidepressant treatment.
Simon GE; Savarino J; Operskalski B; Wang PS
Am J Psychiatry; 2006 Jan; 163(1):41-7. PubMed ID: 16390887
[TBL] [Abstract][Full Text] [Related]
35. Suicide risk after nonfatal self-harm: a national cohort study, 2000-2008.
Runeson B; Haglund A; Lichtenstein P; Tidemalm D
J Clin Psychiatry; 2016 Feb; 77(2):240-6. PubMed ID: 26301588
[TBL] [Abstract][Full Text] [Related]
36. Antidepressants and suicidal behaviour in late life: a prospective population-based study of use patterns in new users aged 75 and above.
Hedna K; Andersson Sundell K; Hamidi A; Skoog I; Gustavsson S; Waern M
Eur J Clin Pharmacol; 2018 Feb; 74(2):201-208. PubMed ID: 29103090
[TBL] [Abstract][Full Text] [Related]
37. Adolescent self-harm with and without suicidality: cross-sectional and longitudinal analyses of a Swedish regional register.
Bjureberg J; Ohlis A; Ljótsson B; D'Onofrio BM; Hedman-Lagerlöf E; Jokinen J; Sahlin H; Lichtenstein P; Cederlöf M; Hellner C
J Child Psychol Psychiatry; 2019 Mar; 60(3):295-304. PubMed ID: 30207392
[TBL] [Abstract][Full Text] [Related]
38. Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000-2014.
Nelson JC; Spyker DA
Am J Psychiatry; 2017 May; 174(5):438-450. PubMed ID: 28135844
[TBL] [Abstract][Full Text] [Related]
39. Predictors of quetiapine extended-release formulation add-on in older patients exposed to antidepressant drugs: A Danish register-based cohort study.
Hashimi H; Andersen M; Sessa M
Int J Geriatr Psychiatry; 2020 Oct; 35(10):1156-1162. PubMed ID: 32428273
[TBL] [Abstract][Full Text] [Related]
40. Comparisons of the risk of medication noncompliance and suicidal behavior among patients with depressive disorders using different monotherapy antidepressants in Taiwan: A nationwide population-based retrospective cohort study.
Su KP; Lu N; Tang CH; Chiu WC; Chang HC; Huang KC
J Affect Disord; 2019 May; 250():170-177. PubMed ID: 30856494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
